|
2 Companies |
|
1 Product |
|
1 Product |
|
3 Mechanisms of Action |
|
0 Trials |
|
8 News |
|
- || Norditropin (somatropin) / Novo Nordisk
Trial primary completion date: Special Survey for Long Term Application (clinicaltrials.gov) - Feb 27, 2017
P=N/A, N=395, Completed, Sponsor: Novo Nordisk A/S
Trial primary completion date: Mar 2006 --> Mar 2007
- || Norditropin (somatropin) / Novo Nordisk
Enrollment change: A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin (clinicaltrials.gov) - Nov 28, 2016
P=N/A, N=81, Completed, Sponsor: Novo Nordisk A/S
Trial primary completion date: Mar 2006 --> Mar 2007 N=54 --> 81
- || Norditropin (somatropin) / Novo Nordisk
Trial initiation date: A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin (clinicaltrials.gov) - Aug 25, 2016
P=N/A, N=54, Completed, Sponsor: Novo Nordisk A/S
N=54 --> 81 Initiation date: May 1997 --> Nov 2012
- ||| Norditropin (somatropin) / Novo Nordisk
Trial completion, Enrollment change: A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin (clinicaltrials.gov) - Jan 16, 2016
P=N/A, N=54, Completed, Sponsor: Novo Nordisk A/S
Initiation date: May 1997 --> Nov 2012 Enrolling by invitation --> Completed | N=300 --> 54
- ||| Trial completion: C-Type Natriuretic Peptide and Achondroplasia (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=91, Completed, Sponsor: Nemours Children's Clinic
Enrolling by invitation --> Completed | N=300 --> 54 Active, not recruiting --> Completed
- || Enrollment closed: C-Type Natriuretic Peptide and Achondroplasia (clinicaltrials.gov) - Oct 2, 2014
P=N/A, N=100, Active, not recruiting, Sponsor: Nemours Children's Clinic
Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- ||| Voxzogo (vosoritide) / BioMarin
Trial completion: A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers (clinicaltrials.gov) - Jun 6, 2012
P1, N=74, Completed, Sponsor: BioMarin Pharmaceutical
Enrolling by invitation --> Active, not recruiting Recruiting --> Completed
- ||| Voxzogo (vosoritide) / BioMarin
New P1 trial: A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers (clinicaltrials.gov) - May 1, 2012
P1, N=74, Completed, Sponsor: BioMarin Pharmaceutical